Seasonal Affective Disorder
📧 Sign up to get email alerts when something new happens for Seasonal Affective Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-08-30FDA Approved: WELLBUTRIN XL — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for Wellbutrin XL (bupropion hydrochloride) submitted by Bausch Health US LLC.
-
FDA approval · 2016-08-19FDA Approved: BUPROPION HYDROCHLORIDE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved an original application for a generic version of bupropion hydrochloride. This expands access to the antidepressant and smoking…
-
FDA approval · 2016-07-15FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Epic Pharma LLC)
FDA approved a Supplemental Application for bupropion hydrochloride (Epic Pharma LLC), signaling regulatory approval for this generic produc…
-
FDA approval · 2016-04-25FDA Approved: WELLBUTRIN SR — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for WELLBUTRIN SR (bupropion hydrochloride) submitted by GlaxoSmithKline LLC. The action confirms th…
-
CLINICAL_TRIALS trial_result · 2016-03-28Clinical Trial Update: Research Study of Treatment for Winter Depression With Different Colors of Light [Phase 2]
Phase 2 trial results evaluating colored light therapy for Seasonal Affective Disorder (winter depression) have been posted from a study con…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-02-09FDA Approved: BUPROPION HYDROCHLORIDE (SR) — Original Application (Cipla USA Inc.,)
The FDA approves Cipla USA Inc.'s original application for a generic sustained-release formulation of bupropion hydrochloride (SR).
-
CLINICAL_TRIALS trial_result · 2016-01-07Clinical Trial Update: Study of Genes in Relation to Seasonal Affective Disorder and Major Depressive Disorder
A completed University of Pittsburgh study investigated genetic factors related to Seasonal Affective Disorder and Major Depressive Disorder…
-
FDA approval · 2015-11-10FDA Approved: BUPROPION — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Bupropion submitted by Zydus Pharmaceuticals USA Inc. The approval indicates changes to the prod…
-
FDA approval · 2015-09-11FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for generic bupropion hydrochloride from Aurobindo Pharma Limited, confirming continued approval and…
-
FDA approval · 2015-06-14FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Bupropion hydrochloride sustained-release (Actavis) to continue marketing the generic product.
-
CLINICAL_TRIALS trial_result · 2015-06-04Clinical Trial Update: Prevention of Seasonal Affective Disorder [Phase 3]
Phase 3 clinical trial update for prevention of Seasonal affective disorder has completed; sponsor listed as GlaxoSmithKline.
-
CLINICAL_TRIALS trial_result · 2015-06-03Clinical Trial Update: Clinical Trials of Three Non-Drug Treatments for Winter Depression (SAD) [NA]
A completed update on three non-drug treatment trials for Seasonal Affective Disorder (winter depression).
-
FDA approval · 2015-05-26FDA Approved: BUPROPION HYDROCHLORIDE SR — Original Application (Solco Healthcare US LLC)
FDA approval of a generic Bupropion Hydrochloride sustained-release tablet (Solco Healthcare US LLC).
-
FDA approval · 2015-05-16FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Apnar Pharma LP)
FDA approved a supplemental application for Apnar Pharma LP's generic Bupropion hydrochloride, confirming approval to market the product wit…
-
FDA approval · 2014-12-30FDA Approved: WELLBUTRIN XL — Supplemental Application (Bausch Health US LLC)
FDA approved a supplemental application for WELLBUTRIN XL (bupropion hydrochloride) from Bausch Health US LLC.
-
FDA approval · 2014-12-20FDA Approved: BUPROPION HYDROCHLORIDE XL — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Bupropion Hydrochloride XL from Actavis Pharma, Inc., formalizing approval of an extended-releas…
-
FDA approval · 2014-12-18FDA Approved: BUPROPION HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries, Inc.'s original application for a generic bupropion hydrochloride product. The approval covers i…
-
FDA approval · 2014-12-01FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for bupropion hydrochloride from Amneal Pharmaceuticals of New York LLC, confirming a regulatory act…
-
FDA approval · 2014-11-20FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for bupropion hydrochloride from Sun Pharmaceutical Industries, indicating an approved addition or m…
-
FDA approval · 2014-11-20FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Epic Pharma LLC)
FDA approved a supplemental application for BUPROPION HYDROCHLORIDE from Epic Pharma LLC under an ANDA.
-
FDA approval · 2014-11-20FDA Approved: BUPROPION HYDROCHLORIDE SR — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Bupropion hydrochloride sustained-release (Bupropion HCl SR) from Actavis Pharma, Inc. under the…
-
FDA approval · 2014-09-24FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Apnar Pharma LP)
FDA approved a supplemental application for Bupropion hydrochloride (Apnar Pharma LP) under an ANDA.
-
FDA approval · 2014-07-17FDA Approved: WELLBUTRIN SR — Supplemental Application (GlaxoSmithKline LLC)
FDA approved a supplemental application for WELLBUTRIN SR (bupropion hydrochloride) from GlaxoSmithKline, updating the labeling through a su…
-
FDA approval · 2014-07-11FDA Approved: WELLBUTRIN XL — Supplemental Application (Bausch Health US LLC)
The FDA approved a supplemental application for Wellbutrin XL (bupropion hydrochloride) submitted by Bausch Health US LLC.
-
CLINICAL_TRIALS trial_result · 2014-06-25Clinical Trial Update: Cognitive Behavioral Therapy for the Treatment of Seasonal Affective Disorder (SAD) [Phase 1]
Phase 1 trial evaluating Cognitive Behavioral Therapy for Seasonal Affective Disorder; the study completed and results were posted.